Citadel Advisors’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $23.8M | Sell |
|
|||||
|
2025
Q2 | $29.5M | Buy |
|
|||||
|
2025
Q1 | $22.1M | Sell |
|
|||||
|
2024
Q4 | $39.1M | Buy |
|
|||||
|
2024
Q3 | $44.3M | Sell |
|
|||||
|
2024
Q2 | $53.9M | Sell |
|
|||||
|
2024
Q1 | $41.4M | Sell |
|
|||||
|
2023
Q4 | $33.1M | Buy |
|
|||||
|
2023
Q3 | $32.1M | Buy |
|
|||||
|
2023
Q2 | $46.9M | Hold |
|
|||||
|
2023
Q1 | $50.3M | Buy |
|
|||||
|
2022
Q4 | $3.18M | Buy |
|
|||||
|
2022
Q3 | $217K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $509K | Buy |
|